ED50 of Intratecal Prilocaine in Ultrasound Fusion Prostate Biopsy
Status:
Recruiting
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
The aim of the present study was to determine the ED50 and ED90 of intrathecal hyperbaric 2%
prilocaine (HP) for patients undergoing ambulatory prostate biopsy via magnetic resonance
imaging (MRI)/ultrasound fusion.